CNW Headlines
Home » Roth Conference

Category: Roth Conference

TuesdayApr 06, 2021 12:52 pm

Roth Provides Additional Details for Virtual Golden Cannabis Day

On April 7th, Roth is hosting a Virtual Cannabis Day designed to provide access to the top U.S. and global public and private cannabis operators, including the leading MSOs. The team is scheduling 1-on-1/small group meetings for institutional investors to meet with leading health and wellness companies. In addition, the day will be highlighted by a panel on Cannabis Brands with the leading brand innovators. Please contact your Roth sales representative if you would like to attend.  Public companies available for 1x1 meetings: 4Front (CSE: FFNT) (OTCQX: FFNTF) | Ayr Wellness (CSE: AYR.A) (OTCQX: AYRWF) | Ceres/Parallel (OTCQX: CERAF) Charlotte's…

Continue Reading

WednesdayMar 15, 2017 12:30 pm

22nd Century Group, Inc. (NYSE: XXII) Starts Presentation at 29th Annual ROTH Conference

22nd Century (NYSE: XXII) is a plant biotech company providing technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants and the level of cannabinoids in cannabis plants to be decreased or increased through genetic engineering and plant breeding. The company develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. For more information, visit the company’s website at www.xxiicentury.com.…

Continue Reading

TuesdayMar 14, 2017 7:30 pm

InMed Pharmaceuticals, Inc. (IMLFF) Starts Presentation at 29th Annual ROTH Conference

InMed Pharmaceuticals (OTC: IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver. For more information, visit the company’s website at www.inmedpharma.com. About CannabisNewsWire CannabisNewsWire (CNW) provides news aggregation and syndication, enhanced press release services and a full array…

Continue Reading

TuesdayMar 14, 2017 4:00 pm

Intec Pharma Ltd. (NASDAQ: NTEC) Starts Presentation at 29th Annual ROTH Conference

Intec Pharma (NASDAQ: NTEC) is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of drugs by utilizing an efficient gastric retention and specific release mechanism. The company's product pipeline currently includes three product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, currently in phase III; Accordion Pill Zaleplon; and an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel ulcers induced by Nonsteroidal Anti-Inflammatory Drugs. In addition,…

Continue Reading

MondayMar 13, 2017 4:00 pm

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) Starts Presentation at 29th Annual Roth Conference

Zynerba Pharmaceuticals (NASDAQ: ZYNE) is a specialty pharmaceutical company that focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The company’s product candidates include ZYN002, which is in Phase I clinical trial for the treatment of refractory epilepsy, Fragile X syndrome, and osteoarthritis; and ZYN001 that is in preclinical stage for the treatment of fibromyalgia and peripheral neuropathic pain. For more information, visit the company’s website at www.zynerba.com. About CannabisNewsWire CannabisNewsWire (CNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution…

Continue Reading

MondayMar 13, 2017 4:00 pm

Nuvectra Corp. (NASDAQ: NVTR) Starts Presentation at 29th Annual ROTH Conference

Nuvectra (NASDAQ: NVTR) is a neuromodulation medical device company that develops and commercializes its neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets in Europe. The company’s Algovita spinal cord stimulation system is used for the treatment of chronic pain of the trunk and limbs. It also provides neural interface technology, components, and systems, as well as NeuroNexus SmartBox portable control and data streaming systems. The company is based in Plano, Texas. For more information, visit the company’s website at www.nuvectramed.com. About CannabisNewsWire CannabisNewsWire (CNW) provides news aggregation and syndication, enhanced press release services and…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

CannabisNewsWire

1108 Lavaca St
Suite 110-CNW
Austin, TX 78701
(512) 354-7000

Copyright © . CannabisNewsWire® / 1108 Lavaca St Suite 110-IBN Austin, TX 78701 (512) 354-7000 / Disclaimers